Epithelial-Mesenchymal Transition and Lung Cancer: Mechanism for Resistance to EGFR-TKIs?

Despite all of the encouraging clinical results with molecularly targeted therapies against non-small cell lung cancer, there are still important and significant questions that continue to vex. The discovery of activating mutations in EGFR radically changed the treatment options for...
Source: The Daily Sign-Out - Category: Pathologists Authors: Tags: Biomarkers in Lung Cancer Epithelial-to-Mesenchymal Transition Non small cell lung cancer Source Type: blogs